Novel psychoactive substances (NPS) are popular “club/party” drugs that first attracted
attention in the UK in 2009 and remained legal until the 2016 Psychoactive Substances Act …

Objective Mephedrone has been recently made illegal in Europe, but little empirical
evidence is available on its impact on human cognitive functions. We investigated acute and …

Novel psychoactive substances (NPS) are compounds designed to mimic the effects of
existing recreational drugs (classical psychoactive substances [CPS]), while eluding …

Background Emerging adults who endorse more positive psychotic-like experiences (PLEs;
bizarre experiences, delusional ideations) may experience greater cannabis-related …

Background There is growing availability of novel psychoactive substances (NPS), including
cognitive enhancers (CEs) which can be used in the treatment of certain mental health …

Nonmedical prescription stimulant use (NPS) is increasing, particularly among college
students. College students typically engage in NPS for cognitive enhancement, recreational …

Objective Cannabis use can result in negative cannabis-related consequences (NCRC),
particularly among individuals high in impulsivity and sensation seeking. Continued …

Background New psychoactive substances (NPS) are a group of substances that mimic
established drugs, eg, cannabinoids, stimulants, and opioids. NPS use has been associated …

Objective Chronic use of synthetic cannabinoids (SCs) has been associated with a wide
range of negative consequences for health including psychotic and affective disturbances …

A growing body of work links posttraumatic stress disorder (PTSD) symptoms and substance
use. Unfortunately, much of the literature has examined associations in isolation (eg, alcohol …